Results 231 to 240 of about 88,842 (261)

Dopamine D3 receptor agents in schizophrenia

European Neuropsychopharmacology, 1999
P. Sokoloff, J. Diaz, C. Pilon, J.-C. Schwartz   +3 more
openaire   +1 more source

The effectiveness of off-label dopamine stimulating agents in depressive disorder: A systematic review and meta-analysis

Psychiatry Research, 2023
Hans W Jeuring, Emile D’Angremont, Iris E C Sommer   +2 more
exaly  

The Effectiveness of Dopamine Stimulating Agents in Depressive Disorder

The American Journal of Geriatric Psychiatry, 2023
openaire   +1 more source

CLEBOPRIDE: A DOPAMINE RECEPTOR BLOCKING AGENT

InPharma, 1982
openaire   +1 more source

Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats.

Neuropharmacology, 2020
Lilian R F Faro, MIGUEL Alfonso, Rafael Duran   +2 more
exaly  

Dopamine agents for the treatment of the negative symptoms of schizophrenia

Schizophrenia Research, 1995
Robert W. Buchanan, William T. Carpenter, Brian Kirkpatrick, Nancy Bryant, Juan Bustillo   +4 more
openaire   +1 more source

Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents:  Potential Therapeutics for Neurological and Psychiatric Disorders

Chemical Reviews, 2007
Ao Zhang, John L Neumeyer, Ross J Baldessarini   +2 more
exaly  

Dopamine Receptor Agents

2007
openaire   +1 more source

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

European Journal of Pharmacology, 1996
Noam Gordon, Moshe Rehavi
exaly  

Hyperactivity induced by injection of dopamine into the accumbens nucleus: Actions and interactions of neuroleptic, cholinomimetic and cholinolytic agents

Neuropharmacology, 1979
B Costall, S C Hui, R J Naylor
exaly